Accrete Health Partners Invests in ReveloHealth to Expand iCALIBRATE Platform

May 27, 2026
ReveloHealth has received a strategic investment from Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health, to expand its iCALIBRATE platform and improve contract performance and reimbursement accuracy.

ReveloHealth has received a strategic investment from Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health, announced in a press release. The funding aims to strengthen contract performance and reimbursement accuracy across health systems, provider groups, and payer relationships.

ReveloHealth plans to use the investment to expand its iCALIBRATE platform and accelerate its national deployments. The platform integrates payer contract terms, claims data, and reimbursement logic to identify discrepancies early in the payment process.

Bon Secours Mercy Health will deploy iCALIBRATE across its physician network to support standardized contract validation and revenue integrity processes. Jason Szczuka, president of Accrete Health Partners and chief digital officer of Bon Secours Mercy Health, will join ReveloHealth's board of directors.

ReveloHealth stated that it will continue to invest in platform innovation, team growth, and partnerships with health systems and provider groups seeking greater control over reimbursement and contract performance.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/27
Compal Electronics and GMI Cloud Partner on AI Infrastructure Deployment
05/27
General Motors Approves Pinnacle Intelligence for Dealership BDC Services
05/27
Adaly Launches Federated DataOS for Enterprise AI Operations
05/27
Investor Group Services Launches AI Practice Led by Justin Bass
05/27
Pump.co Expands Free Platform to Include AI Cost Optimization

More from: Life Sciences

05/27
PartsSource Adds New Asset Uptime Capabilities to Its PRO Platform
05/27
Metabolon Introduces Verus Metabolomics Profiling Kit for Global Research Use
05/27
CPC Biotech and Multiply Labs Partner on Robotic Cell Therapy Manufacturing
05/27
FDA Grants Breakthrough Device Status to Gene Solutions' SPOT-MAS 10 Cancer Screening Test
05/27
Merck KGaA Selects Veeva Vault CRM for Global Use

Subscribe to Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like